Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23657112)

1.

Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362-5.

2.

Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.

3.

Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.

Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA.

Clin Infect Dis. 2011 Oct;53(8):780-6. doi: 10.1093/cid/cir499.

4.

Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.

Jewett A, Smith BD, Garfein RS, Cuevas-Mota J, Teshale EH, Weinbaum CM.

J Clin Virol. 2012 Jul;54(3):213-7. doi: 10.1016/j.jcv.2012.04.003. Epub 2012 May 3.

PMID:
22560051
5.

Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.

Ward JW.

Antivir Ther. 2012;17(7 Pt B):1397-401. doi: 10.3851/IMP2477. Epub 2012 Dec 7. Review.

PMID:
23321543
6.

Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.

Stockman LJ, Guilfoye SM, Benoit AL, Vergeront JM, Davis JP; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.

7.

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS.

N Engl J Med. 1999 Aug 19;341(8):556-62.

8.

[Serological and molecular markers of HCV infection in Polish blood donors].

Brojer E.

Przegl Epidemiol. 2005;59(2):511-7. Review. Polish.

PMID:
16190561
9.

Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.

Coyle C, Viner K, Hughes E, Kwakwa H, Zibbell JE, Vellozzi C, Holtzman D; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):459-63.

10.

Failure to diagnose recent hepatitis C virus infections in London injecting drug users.

Aarons E, Grant P, Soldan K, Luton P, Tang J, Tedder R.

J Med Virol. 2004 Aug;73(4):548-53.

PMID:
15221898
11.

[Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].

Contreras AM, Ochoa-Jiménez RJ, Kershenobich D, Granados-García V, Conde-González CJ, Celis A, Pérez-Gómez HR, Ruelas-Hernández S, Romero-Flores P, Alcántar-Luna E, Sierra-García de Quevedo J, Ancona-Pisté O; Grupo de Desarrollo de la Guía.

Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 2):641-78. Spanish.

PMID:
23593783
12.

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32. Erratum in: MMWR Recomm Rep. 2012 Nov 2;61(43):886.

13.

HIV and hepatitis C virus infection in the United States: whom and how to test.

Panneer N, Lontok E, Branson BM, Teo CG, Dan C, Parker M, Stekler JD, DeMaria A Jr, Miller V.

Clin Infect Dis. 2014 Sep 15;59(6):875-82. doi: 10.1093/cid/ciu396. Epub 2014 May 27. Review.

PMID:
24867787
14.

Use of virologic assays in the diagnosis and management of hepatitis C virus infection.

Chevaliez S, Pawlotsky JM.

Clin Liver Dis. 2005 Aug;9(3):371-82, v. Review.

PMID:
16023971
15.

The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.

Hussein MM, Mooij JM, Hegazy MS, Bamaga MS.

Saudi J Kidney Dis Transpl. 2007 Mar;18(1):107-13.

16.

Outcome of screening for hepatitis C virus infection based on risk factors.

Mallette C, Flynn MA, Promrat K.

Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.

PMID:
17894850
17.
18.

Tests and screening strategies for the diagnosis of hepatitis C.

Carey W.

Cleve Clin J Med. 2003 Sep;70 Suppl 4:S7-13. Review.

PMID:
14558640
19.

Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.

Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM.

Transfusion. 2002 Nov;42(11):1501-6.

PMID:
12421225
20.

Hepatitis C: Part I. Routine serologic testing and diagnosis.

Moyer LA, Mast EE, Alter MJ.

Am Fam Physician. 1999 Jan 1;59(1):79-88, 91-2. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk